Lethal intoxication with antidepressives and neuroleptics. Analysis considering indication practice in Vienna from 1991 to 1997;Letale intoxikationen mit anti-depressiva und neuroleptika. Analyse im zusammenhang mit den verordnungen in Wien von 1991 bis 1997

Nervenarzt

Volumn 73, Issue 7, 2002, Pages 629-636

  Frey, R ^a   Schreinzer, D ^a   Stimpfl, T ^b   Vycudilik, W ^b   Berzlanovich, A ^b   Kasper, S ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

^b UNIVERSITY OF VIENNA   (Austria)

Author keywords

Antidepressants; Intoxication; Neuroleptics; Prescription; Suicide

Indexed keywords

AMITRIPTYLINE; BUTYROPHENONE; CHLORPROTHIXENE; CITALOPRAM; CLOZAPINE; DIXYRAZINE; DOXEPIN; FLUOXETINE; FLUPENTIXOL; FLUPHENAZINE; HALOPERIDOL; LEVOMEPROMAZINE; MAPROTILINE; MELPERONE; MIANSERIN; NEUROLEPTIC AGENT; OLANZAPINE; PAROXETINE; PERPHENAZINE; PIMOZIDE; PROTHIPENDYL; SERTRALINE; SULPIRIDE; THIORIDAZINE; TIAPRIDE; TRICYCLIC ANTIDEPRESSANT AGENT; TRIFLUPROMAZINE; UNINDEXED DRUG; ZOTEPINE; ZUCLOPENTHIXOL; ANTIDEPRESSANT AGENT;

ARTICLE; DRUG FATALITY; DRUG INDICATION; DRUG INTOXICATION; DRUG USE; HUMAN; PRESCRIPTION; PREVALENCE; SUICIDAL BEHAVIOR; AUSTRIA; CAUSE OF DEATH; COMPARATIVE STUDY; DOSE RESPONSE; DRUG INTERACTION; DRUG UTILIZATION; INTOXICATION; MORTALITY; PSYCHOLOGICAL ASPECT; RETROSPECTIVE STUDY; RISK; STATISTICS; SUICIDE;

ANTIDEPRESSIVE AGENTS; ANTIPSYCHOTIC AGENTS; AUSTRIA; CAUSE OF DEATH; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG INTERACTIONS; DRUG UTILIZATION; HUMANS; OVERDOSE; POISONING; PRESCRIPTIONS, DRUG; RETROSPECTIVE STUDIES; RISK; SUICIDE;

EID: 0036882243     PISSN: 00282804     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00115-001-1255-2     Document Type: Article

References (30)

1. Alsén M, Ekedahl A, Löwenhielm P, Niméus A, Regnéll G, Träskman-Bendz L (1994) Medicine self-poisoning and the sources of the drugs in Lund, Sweden. Acta Psychiatr Scand 89: 255-261
2. Barbey JT, Roose SP (1998) SSRI safety in overdose. J Clin Psychiatry 59: 42-48
3. Barraclough BM (1974) Are there safer hypnotics than barbiturates? Lancet 1: 57-58
4. Breier A, Astrachan BM (1984) Characterization of schizophrenic patients who commit suicide. Am J Psychiatry 141: 206-209
5. Buckley NA, Whyte IM, Dawson AH (1995) Cardiotoxicity more common in thioridazine overdose than with other neuroleptics. J Toxicol Clin Toxicol 33: 199-204
6. Buckley N, McManus P (1998) Fatal toxicity of drugs used in the treatment of psychotic illnesses. Br J Psychiatry 172: 461-464
7. Caldwell CB, Gottesman II (1990) Schizophrenics kill themselves too: A review of risk factors for suicide. Schizophr Bull 16: 571-589
8. Cassidy S, Henry J (1987) Fatal toxicity of antidepressant drugs in overdose. BMJ 295: 1021-1024
9. Frey R, Schreinzer D, Stimpfl T, Vycudilik W, Berzlanovich A, Kasper S (2000) Suicide by antidepressant intoxication identified at autopsy in Vienna between 1991 and 1997: the favourable consequences of the increasing use of SSRIs. Eur Neuropsychopharmacol 10: 133-142
10. Henry JA, Alexander CA, Sener EK (1995) Relative mortality from overdose of antidepressants. BMJ 310: 221-224
11. Isacsson G, Holmgren P, Druid H, Bergman U (1997) The utilization of antidepressants - a key issue in the prevention of suicide: an analysis of 5281 suicides in Sweden during the period 1992-1994. Acta Psychiatr Scand 96: 94-100
12. Isacsson G, Boëthius G, Henriksson S, Jones JK, Bergman U (1999) Selective serotonin reuptake inhibitors have broadened the utilisation of antidepressant treatment in accordance with recommendations. Findings from a Swedish prescription database. J Affect Disord S3: 15-22
13. Jonghe de F, Swinkels JA (1992) The safety of antidepressants. Drugs 43 [Suppl 2]:40-47
14. Kasper S, Höflich G, Scholl HP, Möller HJ (1994) Safety and Antidepressant Efficacy of Selective Serotonin Re-uptake Inhibitors. Hum Psychopharmacol 9:1-12
15. Kasper S, Schindler S, Neumeister A (1996) Risk of suicide in depression and its implication for psychopharmacological treatment. Int Clin Psychopharmacol 11: 71-79
16. Keller T, Miki A, Binda S, Dirnhofer R (1997) Fatal overdose of clozapine. Forensic Sci Int 86: 119-125
17. Kresse-Hermsdorf M, Müller-Oerlinghausen B (1990) Tricyclic neuroleptic and antidepressant overdose: epidemiological, electrocardiographic, and clinical features - a survey of 92 cases. Pharmacopsychiatry 23: 17-22
18. Liebelt EL, Francis PD, Woolf AD (1995) ECG lead aVR versus QRS interval in predicting seizures and arrhythmias in acute tricyclic antidepressant toxicity. Ann Emerg Med 26: 195-201
19. Möller HJ (1992) Antidepressants - Do they decrease or increase suicidality? Pharmacopsychiatry 25: 249-253
20. Montgomery SA, Dunner DL, Dunbar GC (1995) Reduction of suicidal thoughts with paroxetine in comparison with reference antidepressants and placebo. Eur Neuropsychopharmacol 5: 5-13
21. Montgomery SA, Kasper S (1995) Comparison of compliance between serotonin reuptake inhibitors and tricyclic antidepressants: A meta-analysis. Int Clin Psychopharmacol 9 [Suppl 4]: 33-40
22. Müller-Oerlinghausen B, Berghöfer A (1999) Antidepressants and suicidal risk. J Clin Psychiatry 60 [Suppl 2]: 94-99
23. Ohberg A, Vuori E, Klaukka T, Lonnqvist J (1998) Antidepressants and suicide mortality. J Affect Disord 50: 225-233
24. Öström M, Eriksson A, Thorson J, Spigset, O (1996) Fatal overdose with citalopram. Lancet 348: 339-340
25. Pfleger K, Maurer HH, Weber A (1992) Mass Spectral and GC Data of Drugs, Poisons, Pesticides, Pollutants and Their Metabolites, 2nd edn. VCH Weinheim, New York Basel Cambridge
26. Schreinzer D, Frey R, Stimpfl T, Vycudilik W, Berzlanovich A, Kasper S (2001) Different fatal toxicity of neuroleptics identified by autopsy. Eur Neuropsychopharmacol 11 (2): 133-142
27. Sporer KA (1995) The serotonin syndrome. Drug Saf 13: 94-104
28. Steentoft A, Worm K, Pedersen CB, Sprehn M, Mogensen T, Sorensen MB, Nielsen E (1996) Drugs in blood samples from unconscious drug addicts after the intake of an overdose. Int J Legal Med 108: 248-251
29. World Health Organisation (2000) Anatomical therapeutic chemical (ATC) classification index including defined daily doses (DDDs) for plain substances. Oslo: WHO Collaborating, Centre for Drug Statistics Methodology
30. Worm K, Dragsholt C, Simonsen K, Kringsholm B (1998) Citalopram concentrations in samples from autopsies and living persons. Int J Legal Med 111: 188-190